Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

New Data: Efficacy And Responder Analyses Of Divigel(R) (estradiol Gel) 0.1 Percent For The Treatment Of Menopause
Upsher-Smith Laboratories, Inc. presented the results of a secondary analysis to determine the response rates to three doses of transdermal Divigel(R) (estradiol gel) 0.1 percent at the recent 57th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG) in Chicago. The objectives of this secondary analysis of a phase III efficacy trial were to determine the percent of postmenopausal women who achieved a greater than 50 percent reduction in the frequency of moderate to severe vasomotor symptoms (MSVMS), or hot flashes, and to assess the change from baseline in a quality of life (Kupperman) index score that evaluated various menopausal symptoms. Divigel(R) doses studied included 1.0 mg, 0.5 mg and 0.25 mg of estradiol/day - the lowest effective approved dose of estradiol available for the treatment of MSVMS. The analysis showed a significantly greater percentage of women in all treatment groups versus placebo experienced > / = 50 percent reduction in the frequency of MSVMS at week 12. In the Divigel(R) 1.0 mg estradiol/day dosing group, 90 percent of women reported at least a 50 percent reduction in the frequency of MSVMS. Additionally, at 12 weeks, each of the doses of Divigel(R) significantly reduced the severity of menopausal symptoms identified by a quality of life index score compared to placebo.
generic viagra online
TeleHealth Services Chosen By HCA To Install Interactive Patient Education System In Timpanogos Regional Hospital
TeleHealth Services, the nation"s leading provider of healthcare grade televisions and on-demand patient and staff interactive education solutions, has announced the implementation of its TIGR on-demand video education and entertainment system into Timpanogos Regional Hospital in Orem, Utah. Drugshop to buy zoloft online and other pills.
News of the day
Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder
Pfizer Inc announced today that Toviaz™ (fesoterodine fumarate) extended release tablets and the YourWay™ plan (http://www.ToviazYourWay.com), a comprehensive, customizable support plan for overactive bladder patients, are available in the United States. Toviaz is a once-daily prescription treatment for patients with symptoms of overactive bladder, which include frequent and sudden urges to urinate and wetting accidents. Toviaz works by helping to calm the bladder muscle that causes frequent, sudden urges to urinate.
Mental Health

2009 Annual Gates Award For Global Health Won By LSHTM

The London School of Hygiene & Tropical Medicine has won the Gates Award for Global Health, and will receive $1 million in prize money. The award was established by the Bill & Melinda Gates Foundation to recognise organizations that have made an outstanding contribution to improving global health, especially in re-poor settings. The winners are chosen by a jury of international health leaders from more than 100 nominations from around the world, and the award is administered by the Global Health Council. The School is both the first academic institution to win the award and the first British winner. "For more than a century, the London School has trained the some of the world"s most outstanding public health leaders", said Dr. Tachi Yamada, president of the Gates Foundation"s global health program. "The School"s commitment to leadership and cutting-edge research has made an immeasurable contribution to health in developing countries". Professor Sir Andrew Haines, Director of LSHTM, comments: "This award is excellent news for the School and a testament to the hard work, commitment and expertise of our staff and students. "We are delighted and proud to be honoured for the work we do which includes researching diseases that particularly afflict disadvantaged people around the world - such as malaria, TB, HIV/AIDS but also increasingly cancer, cardiovascular disease and mental disorders. Equally important is our work to build health systems and train health personnel in low income and post-conflict countries. "This award could not have come at a better time for us as it coincides with plans to expand the School"s popular distance learning programme. This programme has helped many talented people around the world to acquire the skills and expertise they need to improve public health. The prize money will enable us to extend that opportunity to many more through development of new courses and provision of scholarships". With its outstanding performance in the universities" 2008 Research Assessment Exercise (a national exercise to evaluate the quality of research in all UK higher education institutions) and its flourishing teaching programmes, the School is a leading institution in the United Kingdom and worldwide for research and postgraduate education in global health. There are 3,500 postgraduate students from around 120 countries studying in London or by distance learning. Staff are involved in research collaborations in more than 100 countries. The School has a strong commitment to supporting the development of teaching and research capacity in low-income countries, with staff currently based at sites in Africa, Asia, and Latin America. Sir Andrew will receive the award on behalf of the School in Washington, D.C., United States, at a special ceremony during the Global Health Council"s Annual International Conference on Global Health on 28 May 2009. Gemma Howe London School of Hygiene & Tropical Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009